HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,252 | +18.0% | 9,038 | +11.4% | 0.07% | -12.9% |
| Q2 2023 | $292,600 | +114.4% | 8,112 | +127.0% | 0.08% | +93.2% |
| Q1 2023 | $136,491 | -39.5% | 3,574 | -9.9% | 0.04% | -41.3% |
| Q4 2022 | $225,665 | +35.1% | 3,966 | -6.2% | 0.08% | -8.5% |
| Q3 2022 | $167,000 | -13.9% | 4,226 | -4.1% | 0.08% | -31.7% |
| Q2 2022 | $194,000 | -41.0% | 4,407 | -46.6% | 0.12% | -27.3% |
| Q1 2022 | $329,000 | -20.7% | 8,256 | -20.0% | 0.16% | -14.5% |
| Q4 2021 | $415,000 | +24.3% | 10,321 | +25.6% | 0.19% | -10.2% |
| Q3 2021 | $334,000 | +18.4% | 8,215 | +32.5% | 0.22% | +20.8% |
| Q2 2021 | $282,000 | – | 6,200 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |